Addenylosuccinate lyase (ASL) deficiency is a defect in purine de novo
synthesis pathway, The disease has variable clinical presentation inv
olving psychomotor retardation, seizures, hypotonia, and autism. The p
resence of succinyladenosine and succinylamino-imidazole carboxamide r
iboside (SAICA riboside) in body fluids characterizes the biochemical
phenotype. All cases of ASL deficiency described to date have been dia
gnosed in Europe, Using a high-resolution thin-layer chromatography (T
LC) technique combining screening for ASL deficiency and disorders of
saccharide metabolism, me found the first case of this disease in the
US. The patient presented with delayed motor development and profound
hypotonia. The family history and routine laboratory tests were negati
ve, Screening for metabolic disorders detected the presence of succiny
ladenosine and SAICA riboside in urine, The activity of ASL in the pat
ient's skin fibroblasts was 43% of controls (patient, mean = 1.20 nmol
/min/mg of protein, s = 0.21, n = 3; controls, mean = 2.75 nmol/min/mg
of protein, s = 0.61, n = 7), In a 15-month-old girl with profound hy
potonia, we established the diagnosis of ASL deficiency by demonstrati
ng succinyladenosine and SAICA riboside in urine and decreased residua
l activity of ASL in skin fibroblasts. (C) 1997 by Elsevier Science In
c.